New Argentine Food Codex: Resolution 9/2024 Leaves Infant Formula Safety Gaps Galore, Can 180-Day Transition Period Save the Crisis?
On August 15, 2024, the Argentine Government officially issued joint Resolution No. 9/2024, which makes important amendments to the current Argentine Codex Alimentarius. The revision focuses on the following key areas:
First, the government updated the list of additives used in infant formula as carriers of vitamins and other nutrients. This means that in order to ensure that the health and nutritional needs of infants are met, the types and use standards of relevant additives will be further regulated and optimized.
Secondly, the government has made detailed explanations and regulations on the specific ingredients, definitions and labeling requirements of infant formula milk powder. Specifically, the amendments include:
(1) The definition, classification and nutritional content index requirements of infant formula are modified to ensure that the product is more in line with the growth needs of infants and young children;
(2) Clearly require that formula must be gluten-free, and strictly control the content of added fluoride, lead and arsenic to protect the health of infants and young children;
(3) Restrictions are placed on the types and amounts of food additives that can be used in formula milk, such as thickeners, emulsifiers, acidity regulators, etc., to reduce potential health risks.
(4) The main purpose of this revision is to further regulate the infant formula industry in Argentina, improve the quality and safety of products, and thus better protect the rights and interests of consumers. According to the resolution, the new regulations will come into effect the day after publication, and companies will be given a 180-day transition period to allow them enough time to adjust and adapt.
This initiative of the Argentine government fully reflects the high importance attached to the health of infants and young children and is expected to have a positive and far-reaching impact on the development of the country's dairy industry. Relevant enterprises must adjust production and labeling in a timely manner to ensure that products meet the new regulatory requirements to avoid being at a disadvantage in the market competition.
Looking for chemical products? Let suppliers reach out to you!
2026-07-05
-
Functional Ingredients Industry Overview
Collection of Markets for Functional Ingredients in Food & Nutrition and Cosmetics.Published in: Mar. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
EFSA Publishes Peer Review on Fungicide Prothioconazole
-
EFSA Deems Extended Use of Bacillolysin Enzyme Safe
-
EU Proposes Approval of Triacylglycerol Lipase as Food Additive
-
EFSA Finds Lavender Tincture Feed Additive Safe for All Animals
-
EU Alerts on Non-Compliant Chinese Oyster Sauce and Miso Exports
-
EFSA Raises Neotame Safety Limit by 5 Times Confirms No Health Risks
-
Maine’s Cozy Harbor Seafood Files Chapter 11 Bankruptcy Owes Over $5 Million
-
Allterra Targets 17 Billion BRL Market with Three New Bioproducts for Soil Health
-
SML Launches 2 Breakthrough Bioproducts to Boost Indian Crop Yields Amid Climate Change
-
Biochem to Acquire BASF’s Global Glycinates Business
Recommend Reading
-
EPA Reviews Bayer’s New Fungicide Fluoxapiprolin for US Crops Disease Control Expanded Risk Assessed as Low
-
Brazil Launches EficazControl Biocontrol Agent Yields Up 3.71 Bags per Hectare Approved for Soybean Corn Disease Protection
-
Ecuador Shrimp Exports to US Face 15 Percent Tariff $170 Million Extra Cost Threatens 300000 Jobs
-
Global Food Policy Shift 60-Day Rice Import Ban in Philippines EU Issues 5 Recalls on Chinese Exports in One Week
-
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
Eli Lilly to Raise UK Mounjaro Price 170 Percent Monthly Cost Jumps from £122 to £330
-
FDA Approves Precigen’s Papzimeos Immunotherapy 51 Percent of RRP Patients Avoid Surgery for One Year
-
Eli Lilly Strikes $1.3 Billion AI Deal with Superluminal for Next-Gen Obesity Drugs Targets GPCR Breakthrough
-
Premium Global Chemical Sourcing Requests (11–15 Aug 2025)
-
Univar Solutions and BASF Expand Distribution Agreement